# Conclusions (Section 6) — Draft v2 (BiB submission, LORE 3-contribution pattern)

> Living draft. Day 24 reframe for Briefings in Bioinformatics submission.
> Restructured from 3-findings (Day 20 baseline ~208 words) to LORE-style 3-contributions (~290 words).
> Pattern source: LORE (Li et al., BiB 2025, bbaf070) Conclusion structure:
>   1. Novel framework addressing methodological gap
>   2. Demonstrated efficacy via specific findings
>   3. Reusable assets (code + taxonomy + corpus)
>   + portability closing + future-extension closing
> Day 20 baseline preserved on main at commit 90697ce.

---

## §6 Conclusions

In summary, this study makes three principal contributions. First, we introduce a four-method computational framework for systematic analysis of biomedical literature corpora that integrates bibliometric structural mining, citation-burst temporal analysis, large-language-model-augmented topic × mechanism enrichment with false-discovery-rate correction, and three-tier taxonomic stratification—addressing the long-standing methodological gap between aggregate bibliometric views and mechanism-resolved per-paper analysis in pharmacological literature. Second, we demonstrate the framework's efficacy through application to an integrated 9,717-record traditional Chinese medicine herbal–drug interaction corpus, recovering three substantive structural properties not previously documented at the corpus level: a statistically extreme pharmacokinetic–pharmacodynamic bifurcation (maximum mutual exclusion q = 10⁻⁴⁷) that is a 22-year structural invariant rather than a recent trend; a four-method-anchored St. John's wort × CYP3A4 paradigm case with monotonically increasing odds ratios across resolution tiers (family OR = 14.20, species OR = 14.71, compound OR = 18.73); and a mechanism-specific natural resolution layering in which CYP induction concentrates at the chemical-compound tier, UGT inhibition at the botanical-species tier, and transporter modulation at the botanical-family tier. Third, we release reusable assets—an open-source analytical pipeline, the Schema v3 mechanism taxonomy, and a curated 9,717-record cross-database corpus—that complement existing drug-interaction databases and provide ready substrate for extensions to neighbouring pharmacological literature domains. The framework generalizes beyond the traditional Chinese medicine context to any biomedical literature corpus equipped with citation-graph and controlled-vocabulary annotation, supporting resolution-aware approaches to herbal–drug interaction risk stratification. Future work linking the topic-cluster structure identified here to electronic-health-record-derived interaction events will test whether literature-derived structural patterns predict clinically observed adverse drug events.